- MEA pharmaceutical Market reached to $28 B value and 7.86 B units with PPG% -.02 and GAGR -4.6%
- There is a slow growth is some key markets due to COVID 19 , KSA market has grown by 4.2 PPG% compared with Egyptian market 6%PPG
- Top 10 companies represent 37% market share from the MEA
- Sanofi is the biggest player in MEA
- All top 10 are multinational except Hikma although its declining in PPG% compared with previous period
| Sanofi |
| Novartis |
| Pfizer |
| GSK |
| Novo Nordisk |
| MSD |
| Hikma |
| Roche |
| Astra |
| Abbott |
Compare this period with previous one as shown in photo below :
